Search Result "chimeric nucleophosmin-ALK"
Anaplastic Lymphoma Kinase as a Therapeutic Target in Anaplastic Large Cell Lymphoma, Non-Small Cell Lung Cancer and Neuroblastoma
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 10 Issue: 3 Year: 2010 Page: 236-249
Author(s): Mangeng Cheng, Gregory R. Ott
A Review on Anaplastic Lymphoma Kinase (ALK) Rearrangements andMutations: Implications for Gastric Carcinogenesis and Target Therapy
Journal: Current Protein & Peptide Science
Volume: 25 Issue: 7 Year: 2024 Page: 539-552
Author(s): Felipe Pantoja Mesquita,Luina Benevides Lima,Emerson Lucena da Silva,Pedro Filho Noronha Souza,Maria Elisabete Amaral de Moraes,Rommel Mario Rodrigues Burbano,Raquel Carvalho Montenegro
Using Natural Product Inhibitors to Validate Hsp90 as a Molecular Target in Cancer
Journal: Current Topics in Medicinal Chemistry
Volume: 6 Issue: 1 Year: 2006 Page: 1163-1171
Author(s): Len Neckers
A Computer - Aided Drug Designing for Pharmacological Inhibition of Mutant ALK for the Treatment of Non-small Cell Lung Cancer
Journal: Current Topics in Medicinal Chemistry
Volume: 19 Issue: 13 Year: 2019 Page: 1129-1144
Author(s): Saphy Sharda,Ravina Khandelwal,Ritu Adhikary,Diksha Sharma,Manisha Majhi,Tajamul Hussain,Anuraj Nayarisseri,Sanjeev Kumar Singh
The ALK Gene, An Attractive Target for Inhibitor Development
Journal: Current Topics in Medicinal Chemistry
Volume: 11 Issue: 1 Year: 2011 Page: 1406-1419
Author(s): Carmen J. Tartari, Leonardo Scapozza, Carlo Gambacorti-Passerini
MET and ALK as Targets for the Treatment of NSCLC
Journal: Current Pharmaceutical Design
Volume: 20 Issue: 24 Year: 2014 Page: 3914-3932
Author(s): Capelletti M,Gelsomino F.,Tiseo M.
Promising Activity of Mammalian Target of Rapamycin Inhibitors in Hematologic Malignancies Therapy
Journal: Current Signal Transduction Therapy
Volume: 6 Issue: 1 Year: 2011 Page: 44-54
Author(s): Ota Fuchs
Pleiotrophin as a Possible New Target for Angiogenesis-Related Diseases and Cancer
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 2 Issue: 2 Year: 2007 Page: 175-186
Author(s): Constantinos Mikelis, Marina Koutsioumpa, Evangelia Papadimitriou
Macrocyclic Inhibitors of Hsp90
Journal: Current Topics in Medicinal Chemistry
Volume: 10 Issue: 1 Year: 2010 Page: 1380-1402
Author(s): Victoria A. Johnson, Erinprit K. Singh, Lidia A. Nazarova, Leslie D. Alexander, Shelli R. McAlpine
Targeted Therapies and other Agents as First-Line Maintenance and Beyond: Particular Benefit in Pulmonary Adenocarcinoma Patients
Journal: Current Medicinal Chemistry
Volume: 18 Issue: 1 Year: 2011 Page: 1640-1650
Author(s): F. Petrelli, K. Borgonovo, M. Cabiddu, M. Ghilardi, S. Barni